These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 10189557)

  • 1. Dyslipidemia of central obesity and insulin resistance.
    Brunzell JD; Hokanson JE
    Diabetes Care; 1999 Apr; 22 Suppl 3():C10-3. PubMed ID: 10189557
    [No Abstract]   [Full Text] [Related]  

  • 2. The insulin resistance syndrome.
    Smolar EN
    Compr Ther; 1997 Apr; 23(4):237-43. PubMed ID: 9167914
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulin resistance syndrome.
    Cheng TO
    South Med J; 1998 Jul; 91(7):697. PubMed ID: 9671849
    [No Abstract]   [Full Text] [Related]  

  • 4. The insulin resistance-dyslipidemic syndrome of visceral obesity: effect on patients' risk.
    Després JP
    Obes Res; 1998 Apr; 6 Suppl 1():8S-17S. PubMed ID: 9569171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabesity: the deadly pentad disease.
    Daly A
    Diabetes Educ; 1994; 20(2):156-8, 160-2. PubMed ID: 7851230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic complications of obesity. Pathophysiologic considerations.
    Sheehan MT; Jensen MD
    Med Clin North Am; 2000 Mar; 84(2):363-85, vi. PubMed ID: 10793647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Disorders of lipid metabolism in insulin resistance].
    Müller-Wieland D; Krone W
    Herz; 1995 Feb; 20(1):33-46. PubMed ID: 7713475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease is associated with hyperlipidemia and obesity.
    Sharabi Y; Eldad A
    Am J Med; 2000 Aug; 109(2):171. PubMed ID: 11032566
    [No Abstract]   [Full Text] [Related]  

  • 9. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease.
    DeFronzo RA; Ferrannini E
    Diabetes Care; 1991 Mar; 14(3):173-94. PubMed ID: 2044434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation.
    Dandona P; Aljada A; Chaudhuri A; Mohanty P; Garg R
    Circulation; 2005 Mar; 111(11):1448-54. PubMed ID: 15781756
    [No Abstract]   [Full Text] [Related]  

  • 11. [How I investigate...the insulin resistance syndrome using biological markers].
    Luyckx F; Scheen AJ; Gielen J; Lefèbvre PJ
    Rev Med Liege; 1997 Oct; 52(10):686-91. PubMed ID: 9446171
    [No Abstract]   [Full Text] [Related]  

  • 12. [Metabolic syndrome and fatal quartet].
    Standl E
    Internist (Berl); 1996 Jul; 37(7):698-704. PubMed ID: 8766263
    [No Abstract]   [Full Text] [Related]  

  • 13. Insulin resistance and human disease: a short history.
    Reaven GM
    J Basic Clin Physiol Pharmacol; 1998; 9(2-4):387-406. PubMed ID: 10212844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertriglyceridemia secondary to obesity and diabetes.
    Subramanian S; Chait A
    Biochim Biophys Acta; 2012 May; 1821(5):819-25. PubMed ID: 22005032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dyslipoproteinemia and metabolic syndrome. Effects of insulin resistance and hyperinsulinemia on lipid metabolism].
    Krone W; Müller-Wieland D; Wirth H
    Fortschr Med; 1992 Dec; 110(34):645-8. PubMed ID: 1483617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise and the metabolic syndrome.
    Eriksson J; Taimela S; Koivisto VA
    Diabetologia; 1997 Feb; 40(2):125-35. PubMed ID: 9049471
    [No Abstract]   [Full Text] [Related]  

  • 17. The insulin resistance-dyslipidemic syndrome: contribution of visceral obesity and therapeutic implications.
    Després JP; Lemieux S; Lamarche B; Prud'homme D; Moorjani S; Brun LD; Gagné C; Lupien PJ
    Int J Obes Relat Metab Disord; 1995 May; 19 Suppl 1():S76-86. PubMed ID: 7550542
    [No Abstract]   [Full Text] [Related]  

  • 18. Insulin resistance: the clinical spectrum.
    Mantzoros CS; Flier JS
    Adv Endocrinol Metab; 1995; 6():193-232. PubMed ID: 7671097
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of lipids in insulin resistance and type 2 diabetes mellitus development.
    Mingrone G; Castagneto M
    Nutrition; 1999 Jan; 15(1):64-6. PubMed ID: 9918070
    [No Abstract]   [Full Text] [Related]  

  • 20. [Insulin resistance--a physiopathological condition with numerous sequelae: non-insulin-dependent diabetes mellitus (NIDDM), android obesity, essential hypertension, dyslipidemia and atherosclerosis].
    Pedersen O
    Ugeskr Laeger; 1992 May; 154(20):1411-8. PubMed ID: 1631967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.